Figure 1.
OS of patients with HCL treated with subcutaneous cladribine. The median OS was not reached. The survival probability at 10 and 20 years was 80.0% (95% CI, 74.3%-86.0%) and 66.9% (95% CI, 58.4%-76.6%), respectively.

OS of patients with HCL treated with subcutaneous cladribine. The median OS was not reached. The survival probability at 10 and 20 years was 80.0% (95% CI, 74.3%-86.0%) and 66.9% (95% CI, 58.4%-76.6%), respectively.

Close Modal

or Create an Account

Close Modal
Close Modal